Potency, Efficacy and Standardization of a Whole Killed IHN Virus Vaccine

Award Information
Agency: Department of Agriculture
Branch: N/A
Contract: 2005-33610-16080
Agency Tracking Number: 2003-00484
Amount: $296,000.00
Phase: Phase II
Program: SBIR
Awards Year: 2005
Solicitation Year: N/A
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
P.O. Box 408, 259 Main Street, Winterport, ME, 04496
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Eric Anderson
 (207) 223-4662
Business Contact
 Eric Anderson
Phone: (207) 223-4662
Email: mainebiotek@hotmail.com
Research Institution
The salmon and to a lesser extent the trout aquaculture industries in North America consider infectious hematopoietic necrosis virus a major threat to the current and future economic viability and sustainable growth of the industry. As such, development of an efficacious IHN virus vaccine has been identified as top priority of both government and industry organizations in the United States and Canada. The ultimate goal of this project (Phase I-III) is to develop a vaccine for the control of infectious hematopoietic necrosis (IHN) disease of salmon and trout. The specific technical goal and deliverable product of the Phase II project is a pre-commercial IHN virus vaccine prototype. The work plan will address five primary topics related to vaccine performance: vaccine (1) preparation, (2) formulation, (3) potency, (4) safety and (5) efficacy.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government